Oculis Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.6%.

Top 22 shareholders own 44.56% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.6%	LSP Advisory B.V.,	7,324,664	US$90.2m	0%	79.98%
5.6%	Landsbréf Hf.	2,335,841	US$28.8m	0%	55.81%
4.96%	BVCF Management Ltd	2,070,020	US$25.5m	0%	60.61%
4.87%	Pivotal BioVenture Partners LLC	2,032,296	US$25.0m	0%	9.32%
3.2%	Novartis Venture Funds	1,335,492	US$16.4m	0%	100.0%
2.64%	abrdn plc	1,100,432	US$13.5m	-10.4%	0.01%
2.1%	Riad Sherif	878,486	US$10.8m	0%	no data
1.24%	Chen's Group International Limited	516,470	US$6.4m	0%	no data
0.91%	Novartis AG	378,029	US$4.7m	0%	no data
0.6%	Páll Jóhannesson	249,224	US$3.1m	0%	no data
0.23%	Anthony Rosenberg	96,670	US$1.2m	0%	no data
0.23%	Lombard Odier Darier Hentsch & Cie Asset Management	95,750	US$1.2m	0%	0.01%
0.16%	Sylvia Cheung	66,808	US$822.5k	0%	no data
0.12%	ExodusPoint Capital Management, LP	50,366	US$620.1k	0%	0.01%
0.041%	Merrill Lynch & Co. Inc., Banking Investments	17,155	US$211.2k	-13.8%	no data
0.04%	UBS Asset Management AG	16,500	US$203.2k	1,400%	no data
0.036%	Geode Capital Management, LLC	14,944	US$184.0k	0%	no data
0.028%	Christina Ackermann	11,718	US$144.3k	0%	no data
0.021%	State Street Global Advisors, Inc.	8,920	US$109.8k	3.31%	no data
0.00001%	DuPont Capital Management Corporation	4	US$51.4	0%	no data
0.00001%	Royal Bank of Canada, Banking & Securities Investments	4	US$51.4	0%	no data
0%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	US$0	0%	no data